SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy?
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Hank who wrote (3169)3/29/1998 11:20:00 PM
From: Bruce Rosen  Read Replies (2) of 7041
 
<<Yes. The FDA does. I'd be willing to bet the clinical data on Viagra was thorough and complete which is more than I can say about Vasomax.>>

Hank, you have not seen the Viagra data, yet even before it was approved, you had already concluded that Viagra was so superior to Vasomax, that Vasomax had no chance of approval. That is not scientific analysis, it is pure supposition. Schering and the other companies that Zonagen negotiated with had more access to information about Vasomax and Viagra than did you or anyone else on this board and they saw the merits of a marketing deal.

<<Apparently, the FDA must agree since they approved Viagra without questioning the legitimacy of the 70% success rate.>>

Have you seen the FDA commentary or questions regarding Viagra? Are you aware of the exact protocols of the testing on each drug? Might there have been differences in how questions were phrased or in the crafting of primary and secondary endpoints? Might this not have an effect on the statistics showing Viagra to be as superior as you seem so certain that it is?

I am wary of any opinion that does not allow for the possibility that one is wrong. There is much still to learn about impotency and the relative efficacy of its potential treatments. Anyone who claims certainty is almost always wrong about something.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News